Stockholm Syndrome
Stockholm syndrome is a psychological response. It occurs when hostages or abuse victims bond with their captors or abusers. This psychological connection develops over the course of the days, weeks, months, or even years of captivity or abuse.
enter text here
Youtube Video: Stockholm Syndrome
Amazon or Library Book:
Stockholm Syndrome-Bonding With Captors
Click the book to link or order from Amazon.
STAY UP TO DATE:
NEWS FROM PUBMED
- NK cells in COVID-19 - from disease to vaccinationby Quirin Hammer on March 28, 2023
Natural killer (NK) cells participate in the host innate immune response to viral infection. Conversely, NK cell dysfunction and hyperactivation can contribute to tissue damage and immunopathology. Here, we review recent studies with respect to NK cell activity during infection with human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Discussed are initial reports of patients hospitalized with coronavirus disease 2019 (COVID-19), which revealed prompt NK cell activation during the...
- The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemiaby Marja Hakkarainen on March 23, 2023
Biallelic germline ERCC6L2 variants strongly predispose to bone marrow failure (BMF) and myeloid malignancies characterized by somatic TP53-mutated clones and erythroid predominance. We present a series of 52 subjects (35 families) with ERCC6L2 biallelic germline variants collected retrospectively in 11 centers globally, including follow-up of 1165 person-years. At initial investigations, 32 individuals were diagnosed with BMF and 15 with a hematological malignancy (HM). Subjects presented with...
- Bone Tissue Evaluation Indicates Abnormal Mineralization in Patients with Autoimmune Polyendocrine Syndrome Type I: Report on Three Casesby Saila Laakso on March 22, 2023
Autoimmune polyendocrine syndrome type-1 (APS1) is characterized by autoimmune manifestations affecting different organs from early childhood on. Immunological abnormalities, the resulting endocrinopathies, and their treatments may compromise bone health. For the first time in APS1, we analyzed transiliac bone biopsy samples by bone histomorphometry and quantitative backscattered electron imaging in three adult patients (female P1, 38 years; male P2, 47 years; male P3, 25 years). All had...
- Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Studyby Filippo de Braud on March 22, 2023
CONCLUSION: Naporafenib plus trametinib showed promising preliminary antitumor activity in patients with NRAS-mutant melanoma. Prophylactic strategies aimed to lower the incidence of skin-related events are under investigation.